Inositol Signalling
肌醇信号传导
基本信息
- 批准号:7734497
- 负责人:
- 金额:$ 205.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AsthmaBacterial ToxinsBone remodelingCardiacCell LineCell membraneCellsChloride ChannelsChronic BronchitisCystic FibrosisDiseaseEnd PointEnvironmentEquilibriumFluids and SecretionsHealthHeat Stress DisordersHumanInositolInositol PhosphatesInsP5Ion ChannelMetabolicMolecularMuscle ContractionMutationNeoplasm MetastasisNutrientOrganismOsmoregulationPhysiologicalPlayPolyphosphatesProcessRangeRegulationRoleSecond Messenger SystemsShockSignal TransductionSodium ChlorideStimulusStressToxic Environmental SubstancesTranslatingVirus DiseasesWorkcomputerized data processingdeprivationextracellularimprovedinositol heptakisphosphateneurotransmissionneurotransmitter releasenovelresponsesecond messengersensoruptake
项目摘要
An extracellular stimulus evokes a specific response from its target cell - for example, it may command the release or uptake of nutrient, promote neurotransmitter release, or initiate muscle contraction. The information inherent in the stimulus is frequently translated into a format that can then be conveyed by intracellular emissaries: the intracellular levels and hence the activities of these "second messengers" are regulated according to the strength and duration of the original stimulus. This process - signal transduction - is fundamental to how an organism responds and adapts to changes in the environment. Unfortunately, there are many ways it can be disrupted in disease states and by environmental toxins. The adequate treatment of such disturbances requires us to have an understanding of the precise molecular mechanisms that are involved. We study the physiological actions of the inositol polyphosphate second messengers, particularly metabolites of InsP5 and InsP6. We have discovered that InsP5 is metabolically poised to respond to an appropriate cell stimulus by being metabolized to a novel second messenger - an InsP4 - that regulates Ca2+-dependent Cl- channels in the plasma membrane. These ion channels participate in salt and fluid secretion, smooth muscle contraction, neurotransmission, bone remodeling, tumor cell migration, osmoregulation and volume-dependent metabolic effects. With regards to InsP6, we have shown it is a precursor for other important derivatives: the "pyrophosphorylated" polyphosphates. We are exploring the significance of these novel metabolites, and the information uncovered to date strongly suggests they are "high-energy" molecules that act as sensors of specific environmental stress stimulii and nutrient deprivation.
细胞外刺激会引起其靶细胞的特定反应 - 例如,它可以释放或摄取营养,促进神经递质释放或启动肌肉收缩。刺激中固有的信息经常被翻译成一种格式,然后可以通过细胞内使者传达:细胞内级别,因此根据原始刺激的强度和持续时间对这些“第二使者”的活性进行调节。这个过程 - 信号转导 - 是生物体如何反应和适应环境变化的基础。不幸的是,在疾病状态和环境毒素中,有很多方法可以破坏。对这种干扰的适当治疗需要我们了解所涉及的精确分子机制。我们研究了肌醇多磷酸第二信使的生理作用,尤其是Insp5和Insp6的代谢产物。我们已经发现,INSP5通过代谢为适当的细胞刺激做出代谢,通过将新型的第二信使(Insp4)代谢,以调节质膜中Ca2+依赖性Cl-通道。这些离子通道参与盐和液体分泌,平滑肌收缩,神经传递,骨骼重塑,肿瘤细胞迁移,渗透调节和体积依赖性代谢作用。 关于INSP6,我们表明它是其他重要衍生物的前体:“焦磷酸化”的多磷酸盐。我们正在探索这些新型代谢产物的意义,迄今为止发现的信息表明它们是“高能量”分子,它们是特定环境应力刺激和营养剥夺的传感器。
项目成果
期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phosphatidylinositol and inositol phosphate metabolism.
磷脂酰肌醇和磷酸肌醇代谢。
- DOI:10.1242/jcs.114.12.2207
- 发表时间:2001
- 期刊:
- 影响因子:4
- 作者:Abel,K;Anderson,RA;Shears,SB
- 通讯作者:Shears,SB
Inositol 3,4,5,6-tetrakisphosphate inhibits insulin granule acidification and fusogenic potential.
肌醇 3,4,5,6-四磷酸抑制胰岛素颗粒酸化和融合潜力。
- DOI:10.1074/jbc.c200314200
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:Renstrom,Erik;Ivarsson,Rosita;Shears,StephenB
- 通讯作者:Shears,StephenB
Diphosphoinositol Polyphosphates: The Final Frontier for Inositide Research?
- DOI:10.1515/bc.1999.117
- 发表时间:1999-07
- 期刊:
- 影响因子:0
- 作者:S. Safrany;J. Caffrey;X. Yang;S. Shears
- 通讯作者:S. Safrany;J. Caffrey;X. Yang;S. Shears
Transcriptional regulation: a new dominion for inositol phosphate signaling?
转录调控:肌醇磷酸信号传导的新领域?
- DOI:10.1002/1521-1878(200009)22:9<786::aid-bies3>3.0.co;2-0
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Shears,SB
- 通讯作者:Shears,SB
Rounding up the usual suspects: protein kinases as therapeutic targets.
总结常见的怀疑点:蛋白激酶作为治疗靶点。
- DOI:10.1016/s1359-6446(04)03324-0
- 发表时间:2005
- 期刊:
- 影响因子:7.4
- 作者:Shears,StephenB
- 通讯作者:Shears,StephenB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN B SHEARS其他文献
STEPHEN B SHEARS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN B SHEARS', 18)}}的其他基金
相似国自然基金
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
- 批准号:82371775
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
鲜用蒲公英拮抗细菌外毒素感染的物质微观结构基础及其关联作用机制
- 批准号:82274220
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
质粒编码的新型VapBC毒素-抗毒素系统介导CR-hvKp持留态细菌形成的分子机制
- 批准号:82272374
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
质粒编码的新型VapBC毒素-抗毒素系统介导CR-hvKp持留态细菌形成的分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
巨噬细胞外泌体膜融合脂质体对细菌内外毒素清除作用及机制研究
- 批准号:L2124003
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Probiotics and Bone Health - Role of Gender and Intestinal Health
益生菌和骨骼健康 - 性别和肠道健康的作用
- 批准号:
7991060 - 财政年份:2010
- 资助金额:
$ 205.42万 - 项目类别:
Probiotics and Bone Health - Role of Gender and Intestinal Health
益生菌和骨骼健康 - 性别和肠道健康的作用
- 批准号:
8090498 - 财政年份:2010
- 资助金额:
$ 205.42万 - 项目类别:
Mechanisms of Oral Bacteria-Mediated Bone Resorption via Toll-Like Receptors
口腔细菌通过 Toll 样受体介导的骨吸收机制
- 批准号:
7622625 - 财政年份:2008
- 资助金额:
$ 205.42万 - 项目类别:
Mechanisms of Oral Bacteria-Mediated Bone Resorption via Toll-Like Receptors
口腔细菌通过 Toll 样受体介导的骨吸收机制
- 批准号:
7509075 - 财政年份:2007
- 资助金额:
$ 205.42万 - 项目类别:
Mechanisms of Oral Bacteria-Mediated Bone Resorption via Toll-Like Receptors
口腔细菌通过 Toll 样受体介导的骨吸收机制
- 批准号:
8077412 - 财政年份:
- 资助金额:
$ 205.42万 - 项目类别: